Literature DB >> 6088681

Host genetic control of mouse hepatitis virus type 4 (JHM strain) replication. I. Restriction of virus amplification and spread in macrophages from resistant mice.

R L Knobler, L A Tunison, M B Oldstone.   

Abstract

Peritoneal macrophages were used to analyse host genetic control of mouse hepatitis virus type 4 (MHV-4) infection. Both infectious centre and immunofluorescence assays indicated that only a subset of macrophages from either susceptible (BALB, C3H or C57BL/6J) or resistant (SJL/J) mice were initially infected with MHV-4 during the first cycle of infection. However, compared to macrophages from susceptible mice, three- to sixfold fewer SJL/J macrophages were infected, and there was no amplification of virus replication by involvement of adjacent cells during the second cycle of infection. Treatment of macrophages from susceptible mice with interferon beta could not duplicate the aborted second cycle of infection that occurred in macrophages from resistant mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088681     DOI: 10.1099/0022-1317-65-9-1543

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  Mouse hepatitis virus nasoencephalopathy is dependent upon virus strain and host genotype.

Authors:  S W Barthold; D S Beck; A L Smith
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV.

Authors:  G S Dveksler; M N Pensiero; C B Cardellichio; R K Williams; G S Jiang; K V Holmes; C W Dieffenbach
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  In vivo and in vitro models of demyelinating disease: efficiency of virus spread and formation of infectious centers among glial cells is genetically determined by the murine host.

Authors:  G A Wilson; S Dales
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

4.  Purification of the 110-kilodalton glycoprotein receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a nonfunctional, homologous protein in MHV-resistant SJL/J mice.

Authors:  R K Williams; G S Jiang; S W Snyder; M F Frana; K V Holmes
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

5.  Purified, soluble recombinant mouse hepatitis virus receptor, Bgp1(b), and Bgp2 murine coronavirus receptors differ in mouse hepatitis virus binding and neutralizing activities.

Authors:  B D Zelus; D R Wessner; R K Williams; M N Pensiero; F T Phibbs; M deSouza; G S Dveksler; K V Holmes
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  Coronavirus species specificity: murine coronavirus binds to a mouse-specific epitope on its carcinoembryonic antigen-related receptor glycoprotein.

Authors:  S R Compton; C B Stephensen; S W Snyder; D G Weismiller; K V Holmes
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

7.  The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection.

Authors:  K Yokomori; M M Lai
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

8.  Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59.

Authors:  G S Dveksler; C W Dieffenbach; C B Cardellichio; K McCuaig; M N Pensiero; G S Jiang; N Beauchemin; K V Holmes
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

9.  Thymus involution induced by mouse hepatitis virus A59 in BALB/c mice.

Authors:  C Godfraind; K V Holmes; J P Coutelier
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  The Role of Host Genetic Factors in Coronavirus Susceptibility: Review of Animal and Systematic Review of Human Literature.

Authors:  Marissa LoPresti; David B Beck; Priya Duggal; Derek A T Cummings; Benjamin D Solomon
Journal:  medRxiv       Date:  2020-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.